Bladder cancer – Basic Information

Go back

Bladder cancer is a disease that begins when cells in the bladder start growing out of control, forming tumors in the tissue that lines this small, hollow organ responsible for storing urine. Most cases are caught relatively early and can be treated, but the disease has a frustrating tendency to return even after successful treatment, requiring patients to remain watchful and undergo regular check-ups for many years.

Understanding How Common Bladder Cancer Is

Bladder cancer ranks as the sixth most common cancer in the United States, with approximately 82,000 new cases diagnosed each year and around 17,000 deaths annually.[13] Worldwide, it stands as the ninth most common cancer, with an estimated 550,000 new cases and 200,000 deaths globally in 2017.[13] This disease predominantly affects older adults, with most diagnoses occurring in people over the age of 55.[1]

The disease shows a striking gender difference, affecting men far more frequently than women. Men are approximately four times more likely to develop bladder cancer than women, accounting for about 75% of new cases and deaths.[3][13] The reasons behind this gender gap remain unclear to researchers. However, when women do develop bladder cancer, they often face a more challenging situation because their disease is typically diagnosed at more advanced stages, partly because they may not recognize or pay attention to early warning signs like blood in the urine.[3]

Bladder cancer is particularly notable as the fourth most common cancer specifically in males.[3] In industrialized nations, a specific type called urothelial carcinoma (also known as transitional cell carcinoma) makes up more than 90% of all bladder cancer cases.[4]

What Causes Bladder Cancer

Bladder cancer occurs when cells in the tissue lining the bladder undergo changes that cause them to become abnormal.[3] These cells then multiply uncontrollably and form tumors. The bladder is lined with a special tissue called urothelium, which is made of cells that can stretch when the bladder fills with urine and shrink when it empties.[3] Most bladder cancers start in these urothelial cells.

While researchers understand the basic process of how bladder cancer develops, the exact reasons why certain individuals develop these cellular changes remain complex. The disease appears to result from a combination of genetic factors and environmental exposures that damage the bladder cells over time. As these damaged cells accumulate and continue to multiply, they can eventually form tumors that, if left untreated, may grow through the bladder wall and spread to other parts of the body, including nearby lymph nodes, bones, lungs, or liver.[3]

Risk Factors That Increase Your Chances

Smoking stands out as the single most significant risk factor for bladder cancer. It is thought to be the cause of about half of all bladder cancers.[15] Smokers face three times the risk of developing bladder cancer compared to non-smokers.[1] This heightened risk occurs because as the bladder filters the harmful chemicals ingested through cigarette smoke, the organ’s lining becomes damaged over time.[1]

Age represents another major risk factor, with people over 55 years old facing considerably higher odds of developing the disease.[1] Exposure to harmful chemicals, whether at home or in the workplace, also increases risk. Workers in certain industries where they come into contact with specific chemicals may be more vulnerable to developing bladder cancer.

Previous cancer treatments can elevate risk as well. Individuals who have undergone certain cancer therapies may find themselves at higher risk for bladder cancer later in life.[1] Chronic bladder inflammation is another contributing factor. People who experience long-term irritation or infection of the bladder, including those with chronic bladder conditions, face increased risk.[1][4]

A family history of bladder cancer can also play a role, suggesting that genetic factors may make some people more susceptible to the disease.[1] Additionally, men are at significantly higher risk than women, though the reasons for this gender difference are not entirely clear.[1]

Recognizing the Symptoms

The symptoms of bladder cancer are usually clear and relatively easy to notice, which is why many cases are caught in the early stages.[1] The most common warning sign is blood in the urine, which may be visible to the naked eye or only detectable under a microscope during testing. This symptom, called hematuria, sends most people with bladder cancer to seek medical advice.[5][4]

Other symptoms include frequent urination, where a person feels the need to urinate more often than usual. Painful urination is another common complaint, where passing urine causes discomfort or a burning sensation. Some people experience back pain or unexplained pelvic pain.[1][4] These symptoms can sometimes be mistaken for other less serious conditions, such as urinary tract infections or kidney stones, which is why proper medical evaluation is important.[5]

⚠️ Important
Many bladder cancer symptoms can also be caused by other, less serious conditions. If you notice blood in your urine, experience frequent or painful urination, or have unexplained back or pelvic pain, it is important to see a healthcare provider for proper evaluation. Early detection of bladder cancer significantly improves treatment outcomes.

How to Reduce Your Risk

While it is not possible to prevent bladder cancer entirely, there are several steps you can take to lower your risk. The most important action is to quit smoking if you smoke, or never start if you don’t. Since smoking is responsible for about half of all bladder cancer cases, avoiding tobacco can dramatically reduce your chances of developing the disease.[15]

Staying well hydrated by drinking plenty of fluids, particularly water, may help lower your risk of developing bladder cancer.[15][21] Aim to drink six to eight glasses of water each day. The theory is that drinking more water helps dilute any potentially harmful substances in your urine and ensures they are flushed out of your bladder more quickly.

Following a healthy diet rich in fruits and vegetables may help keep your bladder healthy and reduce cancer risk.[15][21] A nutrient-rich diet also lowers the risk of developing other types of cancers. Try to eat at least five servings of fruits and vegetables every day, along with whole grains.

Regular physical activity is another important preventive measure. Exercise not only helps reduce the risk of cancer recurrence for those who have been treated but also supports overall health and well-being.[15] Even just 30 minutes of moderate exercise daily can make a difference. If you work with chemicals or in an environment where you might be exposed to harmful substances, following proper safety procedures and wearing protective equipment can help reduce your risk.

How the Disease Affects the Body

To understand how bladder cancer affects the body, it helps to know how the bladder normally works. The bladder is a triangle-shaped, hollow organ located in the lower part of the abdomen, centered between the hip bones, above the urethra and below the kidneys.[2][3] It has a muscular wall that allows it to expand to store urine made by the kidneys and then contract to squeeze urine out of the body. A healthy bladder can hold about two cups of urine.[3]

The kidneys work together with the bladder to remove toxins and wastes from the body through urine. Tiny tubules in the kidneys filter and clean the blood, taking out waste products and making urine. This urine then passes from each kidney through long tubes called ureters into the bladder, where it is stored until it passes through another tube called the urethra and leaves the body.[2]

When bladder cancer develops, abnormal cells multiply in the lining of the bladder and form tumors. If these tumors are not treated, they can grow in several ways. Some remain on or near the surface of the bladder lining, which is considered noninvasive bladder cancer.[3] Others may move deeper into the bladder but not reach the muscle, which is called non-muscle-invasive bladder cancer. The most concerning type is muscle-invasive bladder cancer, where the cancer has grown into the bladder wall muscle and may have spread into the fatty layers or tissues outside the bladder.[3]

Most bladder cancers are non-muscle-invasive when first diagnosed.[2] However, even these early-stage cancers can be troublesome because they have a high tendency to come back after treatment. About 75% of early-stage bladder cancers recur, which is why people with bladder cancer need to undergo regular follow-up examinations for many years.[3][14]

If bladder cancer progresses without treatment, it can spread beyond the bladder walls to nearby lymph nodes and then to other areas of the body, including the bones, lungs, or liver.[3] This process is called metastasis. When cancer spreads to distant parts of the body, it becomes much more difficult to treat and the outlook becomes less favorable.

Ongoing Clinical Trials on Bladder cancer

  • Study on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain
  • Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma

    Not recruiting

    1 1
    Spain
  • Study on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Estonia Latvia Romania Spain
  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study of Sacituzumab Govitecan, Zimberelimab, and Domvanalimab for Patients with Muscle Invasive Bladder Cancer Ineligible for Cisplatin Chemotherapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Italy Poland Romania +1
  • Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Finland France Germany Greece +5
  • Study on Atezolizumab with Radiotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

References

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/symptoms-causes/syc-20356104

https://www.cancer.gov/types/bladder

https://my.clevelandclinic.org/health/diseases/14326-bladder-cancer

https://www.ncbi.nlm.nih.gov/books/NBK536923/

https://www.jnj.com/health-and-wellness/5-things-we-now-know-about-bladder-cancer

https://www.cancer.org/cancer/types/bladder-cancer/about/what-is-bladder-cancer.html

https://cancer.ca/en/cancer-information/cancer-types/bladder/what-is-bladder-cancer

https://www.mayoclinic.org/diseases-conditions/bladder-cancer/diagnosis-treatment/drc-20356109

https://news.keckmedicine.org/new-treatment-eliminates-bladder-cancer-in-82-of-patients/

https://www.cancer.gov/types/bladder/treatment

https://www.fredhutch.org/en/diseases/bladder-cancer/treatment.html

https://pubmed.ncbi.nlm.nih.gov/29094888/

https://www.cancerresearch.org/immunotherapy-by-cancer-type/bladder-cancer

https://my.clevelandclinic.org/health/diseases/14326-bladder-cancer

https://www.cxbladder.com/us/blog/managing-life-after-bladder-cancer/

https://www.cancer.org/cancer/types/bladder-cancer/after-treatment/follow-up.html

https://www.cancer.gov/types/bladder/coping

https://www.cancerresearchuk.org/about-cancer/bladder-cancer/living-with/coping

https://www.cancercare.org/publications/417-caregiving_for_a_loved_one_with_bladder_cancer

https://www.cxbladder.com/us/blog/newly-diagnosed-with-bladder-cancer/

https://cinj.org/5-tips-boost-bladder-health

https://www.fightbladdercancer.co.uk/get-help/life-after-cancer-diagnosis/surviving-bladder-cancer/

FAQ

Why does bladder cancer come back so often even after successful treatment?

Bladder cancer has one of the highest recurrence rates of any cancer. About 75% of early-stage bladder cancers return after treatment. This happens because even when the visible tumor is removed, microscopic cancer cells may remain in the bladder lining. These cells can grow into new tumors over time. Additionally, if the conditions that caused the first cancer, such as smoking or chemical exposure, continue, new cancers can develop. This is why people who have had bladder cancer need regular check-ups with their healthcare provider, often including cystoscopy examinations, for many years after treatment.

What is the difference between invasive and non-invasive bladder cancer?

Non-invasive bladder cancer means the cancer is only on or near the surface of the bladder lining and hasn’t grown into deeper layers. Most bladder cancers are non-invasive when first found. Non-muscle-invasive means the cancer has moved deeper into the bladder wall but hasn’t reached the muscle layer. Muscle-invasive bladder cancer is more serious—it has grown into the muscle wall of the bladder and may have spread to nearby tissues or organs. The type of cancer determines the treatment approach and outlook. Non-invasive cancers are usually treated with surgery and medication delivered directly into the bladder, while muscle-invasive cancers often require more aggressive treatment.

Can women develop bladder cancer or is it only a disease that affects men?

Women can definitely develop bladder cancer, though men are four times more likely to get it. About 75% of bladder cancer cases occur in men, but this doesn’t mean women are immune. In fact, when women do get bladder cancer, they often face a more difficult situation because the disease is typically diagnosed at later, more advanced stages. This happens partly because women may dismiss early symptoms like blood in urine as signs of urinary tract infections or menstruation, delaying proper diagnosis. Any woman experiencing blood in her urine, frequent or painful urination, or pelvic pain should see a healthcare provider for evaluation.

If I quit smoking now, will it reduce my risk of bladder cancer?

Yes, quitting smoking can significantly reduce your risk of developing bladder cancer, even if you’ve smoked for many years. Smoking is thought to cause about half of all bladder cancers, and smokers are three times more likely to develop the disease than non-smokers. When you quit, your bladder is no longer exposed to the harmful chemicals from cigarette smoke that damage the bladder lining. While quitting smoking can be challenging, it’s one of the most important steps you can take to protect your bladder health and overall well-being. Healthcare providers can offer support and medications to help you quit successfully.

What does it mean when they say bladder cancer survival rates depend on the stage?

The stage of bladder cancer describes how far the cancer has grown or spread. When bladder cancer is caught early and restricted to the inner layer of the bladder, the five-year survival rate is very high at 96%. For disease that is localized to the bladder but has grown into deeper layers, the rate is 70%. However, if the cancer has spread beyond the bladder to nearby tissues, the five-year survival rate drops to 34%, and for cancer that has spread to distant parts of the body, it’s only 5%. This is why early detection is so important—the earlier bladder cancer is found and treated, the better the chances of successful treatment and long-term survival.

🎯 Key takeaways

  • Bladder cancer is the sixth most common cancer in the U.S., with about 82,000 new cases diagnosed annually, and men are four times more likely to develop it than women.
  • Smoking is the single biggest risk factor, causing about half of all bladder cancers, and smokers face three times the risk of non-smokers.
  • Blood in the urine is the most common symptom that sends people to seek medical care, though other symptoms like frequent or painful urination are also warning signs.
  • Most bladder cancers are caught early before they spread into the muscle, but about 75% of these early-stage cancers return after treatment, requiring ongoing monitoring.
  • More than 90% of bladder cancers are urothelial carcinoma, which starts in the special stretchy cells lining the inside of the bladder.
  • Drinking plenty of water, eating fruits and vegetables, exercising regularly, and never smoking (or quitting if you do) can help reduce your risk of bladder cancer.
  • The five-year survival rate for bladder cancer caught in its earliest stage is 96%, highlighting the critical importance of early detection.
  • Women with bladder cancer are often diagnosed at more advanced stages because they may dismiss symptoms as urinary tract infections or other common conditions.